Proteomics

Dataset Information

0

Plasma factors mediating inhibition of LDL oxidation


ABSTRACT: MS identification of proteins that change with various lipid removal treatments from plasma to be compared with ability to inhibit LDL oxidation

INSTRUMENT(S): TripleTOF 5600

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Debi Swertfeger  

LAB HEAD: Long J. Lu

PROVIDER: PXD006083 | Pride | 2018-11-27

REPOSITORIES: pride

Dataset's files

Source:
Action DRS
Data082616_02 (F025994).mzid_Data082616_02_(F025994).pride.mgf.gz Mzid
Data082616_02 (F025994).pride.mztab.gz Mztab
Data082616_02.wiff Wiff
Data082616_02.wiff.scan Wiff
Data082616_02F025994.mzid.gz Mzid
Items per page:
1 - 5 of 48
altmetric image

Publications

Feasibility of a plasma bioassay to assess oxidative protection of low-density lipoproteins by high-density lipoproteins.

Swertfeger Debi K DK   Rebholz Sandra S   Li Hailong H   Shah Amy S AS   Davidson William Sean WS   Lu Long J LJ  

Journal of clinical lipidology 20180827 6


<h4>Background</h4>Traditionally, the impact of lipoproteins on vascular disease has been evaluated in light of their quantity, that is, cholesterol content, in plasma. However, recent studies of high-density lipoproteins (HDLs) have focused on functionality with regard to atheroprotection. For example, bioassays have emerged to assess the ability of HDL, in its near native plasma environment, to promote cholesterol removal (efflux) from cells. As a result, attention has focused on developing pl  ...[more]

Similar Datasets

2006-09-01 | E-GEOD-5741 | biostudies-arrayexpress
2006-09-01 | GSE5741 | GEO
2016-02-09 | GSE68021 | GEO
2016-02-09 | E-GEOD-68021 | biostudies-arrayexpress
2023-01-09 | PXD036168 | Pride
2022-10-14 | PXD035671 | Pride
2021-05-19 | GSE171413 | GEO
2021-03-31 | GSE163206 | GEO
2023-06-10 | GSE230360 | GEO
2019-03-20 | GSE114722 | GEO